Anke Richters
Overview
Explore the profile of Anke Richters including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
894
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yildirim H, Richters A, Bins A, Postema A, Aarts M, van Oijen M, et al.
Eur Urol Open Sci
. 2025 Mar;
72:42-45.
PMID: 40026657
Patient Summary: Since 2019, systemic treatments for metastatic kidney cancer have shifted from drugs targeting selected proteins to immunotherapy. Our results show trends over time for more favorable characteristics among...
2.
The impact of positive surgical margins after cystectomy on oncological outcomes: a nationwide study
Bosveld J, Nguyen T, Boormans J, Witjes J, van der Heijden A, Mehra N, et al.
BJU Int
. 2024 Dec;
PMID: 39631746
Objective: To evaluate whether surgical margin status, alongside existing postoperative risk indicators, improves the identification of bladder cancer patients who may benefit from adjuvant therapy following radical cystectomy (RC). Methods:...
3.
Slotman E, Richters A, Fransen H, Smilde T, van der Linden Y, Siesling S, et al.
Urol Oncol
. 2024 Nov;
PMID: 39547876
Background: For patients with metastatic bladder cancer (mBC) palliative chemotherapy is one of the main treatment options. Real-world insights into outcomes are available, but a comprehensive overview of specific treatment...
4.
Darphin X, Moor J, Espinosa da Silva C, Richters A, Ozdemir B
Cancer Rep (Hoboken)
. 2024 Jan;
7(2):e1961.
PMID: 38258483
Background: Although male and female cancer patients are distinct in many ways, there is a limited understanding in the differences between male and female biology and differing pharmacokinetic responses to...
5.
Richters A, Robbrecht D, Meijer R, van der Heijden A, Kiemeney L, van den Bosch J, et al.
Eur Urol Open Sci
. 2024 Jan;
59:50-54.
PMID: 38213646
Patient Summary: We assessed the rate of immunotherapy use for patients with metastatic bladder cancer in the Netherlands. Since its introduction, immunotherapy has been used in a minority of patients,...
6.
Liu M, Christ L, Richters A, Ozdemir B
Oncol Lett
. 2023 Aug;
26(3):377.
PMID: 37559593
Female sex is associated with a higher risk for autoimmune diseases (ADs) and immune-related adverse events (irAEs) from immune checkpoint inhibitors (ICIs). While the safety of ICIs in AD cohorts...
7.
Richters A, Yildirim H, Booth C, Vera Badillo F, Kiemeney L, Aben K
JAMA Oncol
. 2023 Jun;
9(8):1144-1147.
PMID: 37289470
No abstract available.
8.
Richters A, van Ginkel N, Meijer R, Wondergem M, Schoots I, Vis A, et al.
BJU Int
. 2023 May;
132(4):420-427.
PMID: 37246479
Objective: To provide insight into the use and staging information on lymph-node involvement added by fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in patients with muscle-invasive bladder cancer (MIBC), based on a...
9.
Ozdemir B, Richters A, Espinosa da Silva C, Berner A
iScience
. 2023 May;
26(4):106212.
PMID: 37153448
Sex differences in cancer risk and outcome are currently a topic of major interest in clinical oncology. It is however unknown to what extent cancer researchers consider sex as a...
10.
van Hoogstraten L, Vrieling A, van der Heijden A, Kogevinas M, Richters A, Kiemeney L
Nat Rev Clin Oncol
. 2023 Mar;
20(5):287-304.
PMID: 36914746
Bladder cancer is among the ten most common cancers globally, causes considerable morbidity and mortality and is, therefore, a substantial burden for health-care systems. The incidence of bladder cancer is...